AbbVie Inc.ABBVNYSE
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-50.0%
5Y CAGR-48.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-50.0%/yr
vs -27.7%/yr prior
5Y CAGR
-48.2%/yr
Consistent
Acceleration
-22.3pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 1.19% |
| 2024 | -17.66% |
| 2023 | -8.44% |
| 2022 | 9.51% |
| 2021 | 29.50% |
| 2020 | 32.00% |
| 2019 | -0.77% |
| 2018 | 34.81% |
| 2017 | 41.46% |
| 2016 | -6.56% |